Fierce Pharma Asia—Daiichi’s €1B expansion; Astellas’ $800M cell-therapy bet; Novartis India’s strategic review aliu Thu, 02/22/2024 - 14:25
While Moderna moves off COVID, Spikevax posts market-share gains on Pfizer rival kdunleavy Thu, 02/22/2024 - 11:04
House Democrats put Teva, Pfizer and Sandoz in the hot seat with new shortage investigation zbecker Thu, 02/22/2024 - 10:23
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel aliu Thu, 02/22/2024 - 10:09
Amid contract manufacturing wind-down, Moderna advances production efforts for cancer programs fkansteiner Thu, 02/22/2024 - 10:08
FDA slams Chinese API maker with warning letter on heels of issuing Form 483 jkeenan Thu, 02/22/2024 - 08:42